Clinical Scorecard: Spinal Ependymomas: An In-Depth Analysis of Molecular Classification, Treatment Protocols, and Clinical Outcomes with Emphasis on Pediatric Cases (Part III of Ependymomas in Various Locations)

At a Glance

Key Highlights

• Spinal ependymomas comprise 1% of childhood CNS neoplasms and are more common in adults.
• Surgical resection is crucial for improving progression-free and overall survival rates.
• Adjuvant radiotherapy is recommended for higher-grade tumors when complete resection is not possible.
• Lifelong surveillance is required due to risks of late recurrence and distant disease.
• MYCN amplification indicates a more aggressive disease course and necessitates intensified monitoring.

Guideline-Based Recommendations

Diagnosis

• Establish symptom onset and progression, followed by neurological examination.
• Use gadolinium-enhanced MRI of the entire neuraxis for diagnosis.

Management

• Aim for gross total resection or maximal safe surgical resection.
• Consider adjuvant radiotherapy for higher-grade tumors.

Monitoring & Follow-up

• Lifelong surveillance imaging is necessary due to recurrence risks.

Risks

• Late recurrence and distant disease are significant risks post-treatment.

Patient & Prescribing Data

Pediatric patients with spinal ependymomas.

Chemotherapy is limited and reserved for young children or those with recurrent/metastatic disease.

Clinical Best Practices

• Maximal safe resection is recommended for symptomatic or progressive lesions.
• Monitor for drop metastases and perform comprehensive neuraxis imaging.

Related Resources & Content

• Source Article